These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14516528)

  • 1. Determination of Myocardial Viability with ECG-Gated Fluorodeoxyglucose F-18 Positron Emission Tomography.
    Bom HS; Vansant JP; Pettigrew RI; Cooke CD; Votaw JR; Garcia EV
    Clin Positron Imaging; 1999 Jul; 2(4):183-190. PubMed ID: 14516528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization.
    vom Dahl J; Eitzman DT; al-Aouar ZR; Kanter HL; Hicks RJ; Deeb GM; Kirsh MM; Schwaiger M
    Circulation; 1994 Nov; 90(5):2356-66. PubMed ID: 7955194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability.
    Baer FM; Voth E; Schneider CA; Theissen P; Schicha H; Sechtem U
    Circulation; 1995 Feb; 91(4):1006-15. PubMed ID: 7850935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose dobutamine electrocardiograph-gated myocardial SPECT for identifying viable myocardium: comparison with dobutamine stress echocardiography and PET.
    Yoshinaga K; Morita K; Yamada S; Komuro K; Katoh C; Ito Y; Kuge Y; Kohya T; Kitabatake A; Tamaki N
    J Nucl Med; 2001 Jun; 42(6):838-44. PubMed ID: 11390545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dobutamine-stress electrocardiographically gated positron emission tomography for detection of viable but dysfunctional myocardium.
    Yamagishi H; Akioka K; Hirata K; Sakanoue Y; Toda I; Yoshiyama M; Teragaki M; Takeuchi K; Yoshikawa J; Ochi H
    J Nucl Cardiol; 1999; 6(6):626-32. PubMed ID: 10608590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between contractile reserve and positron emission tomographic patterns of perfusion and glucose utilization in chronic ischemic left ventricular dysfunction: implications for identification of myocardial viability.
    Mélon PG; de Landsheere CM; Degueldre C; Peters JL; Kulbertus HE; Piérard LA
    J Am Coll Cardiol; 1997 Dec; 30(7):1651-9. PubMed ID: 9385890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gated fluorine 18 fluorodeoxyglucose positron emission tomography: determination of global and regional left ventricular function and myocardial tissue characterization.
    Saab G; Dekemp RA; Ukkonen H; Ruddy TD; Germano G; Beanlands RS
    J Nucl Cardiol; 2003; 10(3):297-303. PubMed ID: 12794629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of myocardial perfusion at rest and during pharmacologic stress to the PET patterns of tissue viability in patients with severe left ventricular dysfunction.
    Di Carli MF; Asgarzadie F; Schelbert HR; Brunken RC; Rokhsar S; Maddahi J
    J Nucl Cardiol; 1998; 5(6):558-66. PubMed ID: 9869477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hibernating myocardium and the 'no reflow' phenomenon: a study of absolute regional myocardial perfusion and glucose metabolism using positron emission tomography in chronic and acute heart disorders].
    Maes A; Nuyts J
    Verh K Acad Geneeskd Belg; 1997; 59(3):133-60. PubMed ID: 9490915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of patterns of perfusion and metabolism in dobutamine-responsive myocardium.
    Sawada S; Elsner G; Segar DS; O'Shaughnessy M; Khouri S; Foltz J; Bourdillon PD; Bates JR; Fineberg N; Ryan T; Hutchins GD; Feigenbaum H
    J Am Coll Cardiol; 1997 Jan; 29(1):55-61. PubMed ID: 8996295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of functional recovery after revascularization in patients with coronary artery disease and left ventricular dysfunction by gated FDG-PET.
    Slart RH; Bax JJ; van Veldhuisen DJ; van der Wall EE; Dierckx RA; de Boer J; Jager PL
    J Nucl Cardiol; 2006; 13(2):210-9. PubMed ID: 16580957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose dobutamine stress gated SPET for identification of viable myocardium: comparison with stress-rest perfusion SPET and PET.
    Yoshinaga K; Katoh C; Noriyasu K; Yamada S; Ito Y; Kuge Y; Kawai Y; Kohya T; Kitabatake A; Tamaki N
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):882-90. PubMed ID: 12111128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of contrast-enhanced MRI with (18)F-FDG PET/201Tl SPECT in dysfunctional myocardium: relation to early functional outcome after surgical revascularization in chronic ischemic heart disease.
    Wu YW; Tadamura E; Yamamuro M; Kanao S; Marui A; Tanabara K; Komeda M; Togashi K
    J Nucl Med; 2007 Jul; 48(7):1096-103. PubMed ID: 17607039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Status of F-18 fluorodeoxyglucose uptake in normal and hibernating myocardium after glucose and insulin loading.
    Sarikaya I; Elgazzar AH; Alfeeli MA; Sharma PN; Sarikaya A
    J Saudi Heart Assoc; 2018 Apr; 30(2):75-85. PubMed ID: 29910577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional evaluation of myocardial viability by 99mTc tetrofosmin gated SPECT--a quantitative comparison with 18F fluorodeoxyglucose positron emission CT (18F FDG PET).
    Kuwabara Y; Watanabe S; Nakaya J; Fujiwara M; Hasegawa R; Matsuno K; Kuroda T; Mikami Y; Fujii K; Himi T; Masuda Y
    Ann Nucl Med; 1999 Jun; 13(3):135-40. PubMed ID: 10435372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessing myocardial viability in chronic myocardial infarct with 18F-fluoro-D-glucose positron emission tomography and 99mTc-MIBI SPECT].
    Schneider CA; Voth E; Theissen P; Wienhard K; Wagner R; Baer FM; Sechtem U; Schicha H
    Z Kardiol; 1994 Feb; 83(2):124-31. PubMed ID: 8165842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical usefulness of ECG-gated 18F-FDG PET combined with 99mTC-MIBI gated SPECT for evaluating myocardial viability and function.
    Yamakawa Y; Takahashi N; Ishikawa T; Uchino K; Mochida Y; Ebina T; Kobayashi T; Matsushita K; Matsumoto K; Kawasaki N; Shimura M; Ohkusu Y; Sumita S; Kimura K; Inoue T; Umemura S
    Ann Nucl Med; 2004 Jul; 18(5):375-83. PubMed ID: 15462399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gated metabolic myocardial imaging, a surrogate for dual perfusion-metabolism imaging by positron emission tomography.
    AlMohammad A; Norton MY; Welch AE; Sharp PF; Walton S
    Open Heart; 2017; 4(2):e000581. PubMed ID: 28878945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ECG-gated 18F-FDG positron emission tomography.
    Hoffmeister HM; Helber U; Franow A; Feine U; Bares R; Seipel L; Müller-Schauenburg W
    Int J Cardiovasc Imaging; 2002 Oct; 18(5):363-72. PubMed ID: 12194677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.
    Bonow RO; Dilsizian V; Cuocolo A; Bacharach SL
    Circulation; 1991 Jan; 83(1):26-37. PubMed ID: 1984883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.